| Timothy B. Sawyer |
Presently, Timothy B. Sawyer occupies the position of President, Chief Executive Officer & Director at Teligent, Inc. He is also on the board of Mylan API, Inc.
He previously held the position of Executive Chairman & Chief Executive Officer at Geritrex Corp., Principal at Winston & Strawn LLP, President-Retail Medicine at 1-800-DOCTORS, Inc., Senior VP-European Commercial Development at Barr Pharmaceuticals, Inc., Senior VP-Corporate Strategic Development at Mylan, Inc. and Executive VP-Global Generic Sales & Marketing at Barr Laboratories, Inc.
Timothy B. Sawyer received an undergraduate degree from the University of Richmond. |
| Alyssa Lozynski |
Presently, Alyssa Lozynski is Chief Financial Officer for Teligent, Inc. Ms. Lozynski is also on the board of Portage Point Partners LLC.
Ms. Lozynski received a graduate degree from Gies College of Business. |
| John E. Celentano |
Presently, John E. Celentano holds the position of Chairman of Teligent, Inc. and Chairman for Sancilio & Co., Inc. Mr. Celentano is also on the board of YourEncore, Inc., Catholic Medical Mission Board, Inc. (former Chairman), J.J. White, Inc. and The Pennington School.
In his past career he held the position of Senior Vice President of Bristol Myers Squibb Co., Director at Sancilio Pharmaceuticals Co., Inc. and Director & Senior Vice President at ImClone LLC.
Mr. Celentano received an undergraduate degree from the University of Delaware and an MBA from Drexel University. |
| Ernest R. de Paolantonio |
Currently, Ernest R. de Paolantonio holds the position of Chief Financial Officer for Teligent, Inc.
In his past career he held the position of Chief Financial Officer, Secretary & Treasurer of BioDelivery Sciences International, Inc., Executive Director-Finance & Controller at Catalent JNP, Inc., Executive Director-Finance & Controller at Actavis, Inc., Chief Financial Officer for CorePharma LLC, Chief Financial Officer of Fortovia Therapeutics, Inc., Principal at United States Surgical Corp., Controller of Taro Pharmaceutical Industries Ltd., Principal at Watson Laboratories, Inc. and Group Controller at GlaxoSmithKline (Pharmaceutical Operations).
Ernest R. de Paolantonio received an MBA from St. Joseph's University and an undergraduate degree from Lycoming College. |
| R. Carter Pate |
Founder of C-Suite Services LLC, Phoenix Effect LLC and Carter Pate, LLC, R. Carter Pate is an entrepreneur and businessperson who has been the head of 12 different companies and occupies the position of Chairman for GlobalStep Holdings LLC, Chief Executive Officer for Phoenix Effect LLC and Chief Executive Officer for Carter Pate, LLC. Mr. Pate is also on the board of Teligent, Inc., ADA-ES, Inc., National Association of Corporate Directors and Option Care Health, Inc. and Chairman at Greensboro College and Member of The American Institute of Certified Public Accountants.
R. Carter Pate previously was Chairman, President & Chief Executive Officer for Sun TV & Appliances, Inc., Chief Executive Officer at ModivCare, Inc. and Chief Executive Officer for ModivCare Solutions LLC (a subsidiary of ModivCare, Inc.), Chief Executive Officer & Director at MV Transportation, Inc., Chief Executive Officer at C-Suite Services LLC, Finance Director at Hudson Financial Partners LLC, Partner at PWS Group, Inc., Chairman for BioScrip, Inc., Chairman at Red Lion Hotels Corp., Chief Executive Officer & Director at Sun Coast Industries LLC and Head-US & Global Infrastructure at PricewaterhouseCoopers LLP.
R. Carter Pate received an undergraduate degree from Greensboro College and a graduate degree from The University of Texas at Dallas. |
| William S. Marth |
William S. Marth is an American businessperson who has been the head of 11 different companies. He is President, Co-Chief Executive Officer & Director at Teva Spanish Holdco, Inc., President of Cephalon, Inc., President for Gemin X Pharmaceuticals US, Inc. and President & Director at AMRI Burlington, Inc. He is also on the board of Teligent, Inc., Heritage Pharmaceuticals, Inc. and Emcure Pharma UK Ltd. and Managing Partner at North Ocean Ventures LLC.
In the past William S. Marth held the position of President & Chief Executive Officer for Albany Molecular Research, Inc., Chairman at Sorrento Therapeutics, Inc., President & Chief Executive Officer of Teva Pharmaceutical Industries Ltd. President & Chief Executive Officer of Teva Pharmaceuticals USA, Inc. and President & Chief Executive Officer for Teva North America (both are subsidiaries of Teva Pharmaceutical Industries Ltd.), President & CEO-North America & Europe at Heritage Pharma Holdings, Inc., Chairman at Association for Accessible Medicines and Chairman at American Society of Health-System Pharmacists.
William S. Marth received an undergraduate degree from the University of Illinois and an MBA from Keller Graduate School of Management. |
| Carole S. Ben-Maimon |
Carole S. Ben-Maimon is a businessperson who founded Alita Pharmaceuticals, Inc. and who has been at the head of 8 different companies. Presently, she is President, Chief Executive Officer & Director at Larimar Therapeutics, Inc. and President, Chief Executive Officer & Director at Chondrial Therapeutics Holdings LLC (a subsidiary of Larimar Therapeutics, Inc.). Dr. Ben-Maimon is also on the board of Teligent, Inc., Bionpharma, Inc. (former Chairman) and Albert Einstein Healthcare Network.
In her past career she occupied the position of President, Chief Executive Officer & Director at Alita Pharmaceuticals, Inc., President & Chief Operating Officer for Teva Branded Pharmaceutical Products R&D, Inc., Vice President-Medical & Regulatory Affairs at Lemmon Co., President, Chief Executive Officer & Director at Chondrial Therapeutics, Inc., President & Director at Barr Pharmaceuticals, Inc., Senior Vice President-Science & Public Policy at Teva Pharmaceuticals USA, Inc., President-Generic Products at Impax Laboratories LLC, Secretary & Senior VP-Corporate Strategy at Brenn Distribution, Inc. and Chairman at Association for Accessible Medicines.
She received an undergraduate degree from Thomas Jefferson University and an undergraduate degree from the University of Pennsylvania. |
| Thomas J. Sabatino |
Mr. Thomas J. Sabatino, Jr., is a Secretary, Executive VP & General Counsel at Tenneco, Inc., a Co-Chairman at The Humane Society of The United States, an Independent Director at Teligent, Inc., a Chairman at The International Institute for Conflict Prevention & Resolut, a Member at Illinois State Bar Association, a Member at Massachusetts Bar Association, a Member at New Jersey State Bar Association, a Member at The State Bar of California, a Member-General Counsel Committee at American Bar Association and a Member-Global Intellectual Property Council at Chamber of Commerce of The United States of America. He is on the Board of Directors at Teligent, Inc., Asthma & Allergy Foundation of America, Equal Justice Works, Trinitas Regional Medical Center and The University of Pennsylvania Law School. Mr. Sabatino was previously employed as an Executive Vice President & General Counsel by Aetna, Inc., a Chief Administrative Officer & Senior Executive VP by Hertz Global Holdings, Inc. /Old/, a Chief Administrative Officer & Senior Executive VP by The Hertz Corp., a Secretary, CAO, Senior EVP & General Counsel by Hertz Rental Car Holding Co., Inc., a Member-Supervisory Board by Alliance Boots GmbH, an Independent Director by Unigene Laboratories, Inc., a Secretary, Chief Administrative Officer & EVP by Walgreen Co., a Secretary, CAO & Executive VP-Global Legal by Walgreens Boots Alliance, Inc., a Secretary, Executive VP & General Counsel by United Continental Holdings, Inc..He received his undergraduate degree from Wesleyan University and a graduate degree from the University of Pennsylvania. |
